With a mission to overcome fragmented cancer care in India, Continental Cancer Centre serves over 40,000 patients, emphasizing not only treatment but also early detection, prevention, and dispelling myths surrounding cancer. Given the significant impact of cancer in India, a unified approach to integrated care is crucial. The center is dedicated to educating communities, debunking myths, and providing a holistic care model that supports patients and their families on every level.
The approach involves personalized medicine by medical oncologists, collaboration with surgical oncologists, and a wider oncology team. Genetic analysis and collaboration with genetic counselors enable the understanding of each patient’s unique DNA profile, facilitating the customization of effective treatment plans. Pharmacogenomics plays a pivotal role in selecting the most effective chemotherapy drugs based on the patient’s genetic makeup.
Advanced radiation oncology services and regular tumor board meetings contribute to comprehensive care, fostering a collaborative atmosphere for clinical decision-making. The core belief at Continental Cancer Centre is in the power of unity and informed decision-making, driven by a commitment to innovation, compassion, and excellence.
Continental Cancer Centre’s commitment to cancer awareness is further exemplified by the introduction of the Early Detection Liquid Biopsy Test, a groundbreaking advancement in cancer detection. Additionally, the center is proud to introduce three genetic tests, namely the Cancer Predisposition Test, Hereditary Cancer Screening Test, and Next-Generation Sequencing-based cfDNA Testing, aiming to empower individuals with proactive health management strategies in the fight against cancer. The collective wisdom and dedication of the team at Continental Cancer Centre are highlighted, emphasizing their commitment to advancing cancer care and nurturing hope for a healthier future.